Dietz Thomas John — SEC insider filings
SEC reporting owner CIK 1574218. 23 insider filings on record with FilingPulse; latest filed 2026-08-27.
Transaction summary — filings shown
Covers all 23 filings on record, filed 2020-08-12 to 2026-08-27. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 3 legs across 2 filings — 52,500 shares, $92,800 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 2 legs across 2 filings — 42,500 shares, $60,702 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 34.
- Largest priced transaction: purchase of 50,000 shares @ $1.43 ($71,580) in Eiger BioPharmaceuticals, Inc., filed 2023-01-25.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Eiger BioPharmaceuticals, Inc. (EIGR) | Director | 6 | 3 legs · 52,500 sh · $92,800 | 1 leg · 22,500 sh · $26,302 | 5 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | Director | 13 | — | 1 leg · 20,000 sh · $34,400 | 16 |
| Paratek Pharmaceuticals, Inc. (PRTK) | Director | 4 | — | — | 13 |
Insider filings — Dietz Thomas John
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-27 | 4 | CYPHERPUNK TECHNOLOGIES INC. (CYPH) | Sale (S): 20,000 @ $1.72 | EDGAR |
| 2026-07-02 | 4 | CYPHERPUNK TECHNOLOGIES INC. (CYPH) | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2026-03-17 | 4 | CYPHERPUNK TECHNOLOGIES INC. (CYPH) | Option exercise (M): 104,500 · Option exercise (M): 104,500 (derivative) @ $0 | EDGAR |
| 2025-12-30 | 4 | CYPHERPUNK TECHNOLOGIES INC. (CYPH) | Option exercise (M): 83,000 · Tax withholding (F): 35,000 @ $1.20 · Option exercise (M): 83,000 (derivative) @ $0 · Grant/award (A): 104,500 (derivative) @ $0 | EDGAR |
| 2025-11-13 | 4 | CYPHERPUNK TECHNOLOGIES INC. (CYPH) | Grant/award (A): 83,000 (derivative) @ $0 | EDGAR |
| 2024-10-04 | 4 | LEAP THERAPEUTICS, INC. (LPTX) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2024-01-31 | 4 | LEAP THERAPEUTICS, INC. (LPTX) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2023-09-21 | 4 | Paratek Pharmaceuticals, Inc. (PRTK) | Disposition to issuer (D): 49,250 · Disposition to issuer (D): 20,000 · Disposition to issuer (D): 7,000 (derivative) · Disposition to issuer (D): 7,000 (derivative) · Disposition to issuer (D): 5,000 (derivative) · Disposition to issuer (D): 5,000 (derivative) · +3 more | EDGAR |
| 2023-08-25 | 4 | LEAP THERAPEUTICS, INC. (LPTX) | Grant/award (A): 17,500 (derivative) @ $0 | EDGAR |
| 2023-04-04 | 4 | LEAP THERAPEUTICS, INC. (LPTX) | Grant/award (A): 175,000 (derivative) @ $0 | EDGAR |
| 2023-03-03 | 4 | Eiger BioPharmaceuticals, Inc. (EIGR) | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2023-02-09 | 4 | Paratek Pharmaceuticals, Inc. (PRTK) | Grant/award (A): 20,000 @ $0 | EDGAR |
| 2023-01-25 | 4 | Eiger BioPharmaceuticals, Inc. (EIGR) | Purchase (P): 50,000 @ $1.43 | EDGAR |
| 2022-12-27 | 4 | Eiger BioPharmaceuticals, Inc. (EIGR) | Sale (S): 22,500 @ $1.17 | EDGAR |
| 2022-09-02 | 4 | LEAP THERAPEUTICS, INC. (LPTX) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2022-03-11 | 4 | Eiger BioPharmaceuticals, Inc. (EIGR) | Grant/award (A): 6,000 @ $0 · Grant/award (A): 24,000 (derivative) @ $0 | EDGAR |
| 2022-02-18 | 4 | Paratek Pharmaceuticals, Inc. (PRTK) | Grant/award (A): 20,000 @ $0 | EDGAR |
| 2022-02-02 | 4 | LEAP THERAPEUTICS, INC. (LPTX) | Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2021-04-12 | 4 | Eiger BioPharmaceuticals, Inc. (EIGR) | Purchase (P): 1,500 @ $8.48 · Purchase (P): 1,000 @ $8.50 | EDGAR |
| 2021-03-15 | 4 | Eiger BioPharmaceuticals, Inc. (EIGR) | Grant/award (A): 5,000 @ $0 · Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2021-02-22 | 4 | Paratek Pharmaceuticals, Inc. (PRTK) | Grant/award (A): 9,000 @ $0 · Grant/award (A): 7,000 (derivative) @ $0 | EDGAR |
| 2021-01-06 | 4 | LEAP THERAPEUTICS, INC. (LPTX) | Grant/award (A): 37,300 (derivative) @ $0 | EDGAR |
| 2020-08-12 | 4 | LEAP THERAPEUTICS, INC. (LPTX) | Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-08-10 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1574218 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs